Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

ImmunGene receives U.S. government grant for antibody-cytokine fusion technology

Nov. 23, 2010

Boehringer Ingelheim and f-star collaborate to discover therapeutic antibodies

Nov. 23, 2010

BioWa licenses Potelligent technology to Agensys

Nov. 16, 2010

Biovista and Pfizer partner to identify new indications for Pfizer drug candidates

Nov. 11, 2010

MacroGenics and Pfizer enter into DART collaboration and license agreement

Oct. 28, 2010

Evotec and Apeiron Biologics collaborate on DREAM modulators for pain

Oct. 28, 2010

Boehringer Ingelheim and MacroGenics to codevelop antibody-based therapeutics

Oct. 27, 2010

Flamel Technologies achieves milestone for extended release interferon beta-1a

Oct. 25, 2010

ERYtech and Genzyme to conduct feasibility studies with new therapeutic enzyme formulation

Oct. 15, 2010

ArQule and Daiichi Sankyo expand new kinase inhibitor discovery collaboration

Oct. 14, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...